See All Slides - tctmd.com

Slides

Presentation TCT 2012

Amazonia Pax (MINVASYS) Program Update

Presenter: Bruno Garcia

October 23, 2012

Presentation TCT 2012

ABSORB (Abbott Vascular) Clinical Program to Date (and EXTEND Results): Strengths, Limitations, Including the 6-month Unknowns of the ABSORB Stent

Presenter: Antonio Bartorelli

October 23, 2012

Presentation TCT 2012

Strut Architecture and Polymer Configuration Modulates Device Outcomes: Current Nonabsorbable DES Systems Will Be Difficult to Improve Upon!

Presenter: Elazer Edelman

October 23, 2012

Presentation TCT 2012

Pro: Femoral!

Presenter: Paul Teirstein

October 23, 2012

Presentation TCT 2012

ELM Presentation(7)

Presenter: Duane Pinto

October 23, 2012

Presentation TCT 2012

State of the Field Keynote: Impact of Emerging Biomaterials on Next-Generation Bioabsorbable Vascular Scaffold Development

Presenter: Syed Hossainy

October 23, 2012

Presentation TCT 2012

TCT-79. Chronic Total Occlusions in Sweden – Report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)

Presenter: Truls R?munddal

October 23, 2012

Presentation TCT 2012

After CTO Recanalization, What Is the Role of Drug-Eluting Devices, Covered Stents, Etc?

Presenter: Thomas Zeller

October 23, 2012

Presentation TCT 2012

The Amaranth Stent: Design and Future Directions

Presenter: Juan Granada

October 23, 2012

Presentation TCT 2012

Radial, Brachial, and Axillary Access: Tips for Success and Traps for Disaster

Presenter: Lindsay Machan

October 23, 2012

Advertisement

Slides

Amazonia Pax (MINVASYS) Program Update

ABSORB (Abbott Vascular) Clinical Program to Date (and EXTEND Results): Strengths, Limitations, Including the 6-month Unknowns of the ABSORB Stent

Strut Architecture and Polymer Configuration Modulates Device Outcomes: Current Nonabsorbable DES Systems Will Be Difficult to Improve Upon!

Pro: Femoral!

ELM Presentation(7)

State of the Field Keynote: Impact of Emerging Biomaterials on Next-Generation Bioabsorbable Vascular Scaffold Development

TCT-79. Chronic Total Occlusions in Sweden – Report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)

After CTO Recanalization, What Is the Role of Drug-Eluting Devices, Covered Stents, Etc?

The Amaranth Stent: Design and Future Directions

Radial, Brachial, and Axillary Access: Tips for Success and Traps for Disaster

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content